PQW
- Product code
- PQW
- Device name
- Alpha-D-Galactosidase A (Gla) Newborn Screening Test System
- Device class
- Class 2
- 21 CFR
- 21 CFR 862.1488
- Medical specialty
- Clinical Chemistry
- Marketing pathway
- 510(K)
- Flag
- Third-party review eligible
- 510(k) clearances (all years, FDA)
- 3 (all years; only the last 3 years are listed here)
FDA classification definition
For quantitative measurement of the activity of alpha-D-galactosidase A (GLA) from newborn dried blood spot specimens.
Official FDA classification page: PQW
Classification and pathway per current FDA publications. Data from openFDA (CC0).